Solutions for Treatment Resistant Cancer

Dedicated to improving health outcomes for
patients by addressing the complexity of cancer

Learn more about OncoSynergy

targeting rare and resistant cancers

Other Solid Cancers

Ovarian and pancreatic cancer, and malignant meningioma.


Our primary focus. The most common and malignant primary brain cancer.

Hematological Maligancies

Drug resistant acute lymphoblastic leukemia.


First-in-class humanized and deimmunized pan-CD29 monoclonal antibody

Best-in-class small molecule heat shock protein modulator


Partners and Collaborators